SEER Nasdaq

Seer Inc - Class A

SEER | $1.67 0.6% 0.6% 730K

(0.0% 1d) (-12.6% 1m) (-55.5% 1y) (0.0% 2d) (0.0% 3d) (-1.2% 7d) (8.75% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 101,416,112
https://seer.bio
Sec Filling | Patents | 60 employees

Seek Inc. is a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that can make them a reality. The Company's Proteograph is an integrated solution consisting of consumables, automation instrumentation and proprietary software that performs deep, unbiased proteomics analysis at scale in a matter of hours. The Company's designed the Proteograph to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution broadly available to life sciences researchers.

housing

add to watch list Paper trade email alert is off

Press-releases

Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
Published: 2024-02-29 (Crawled : 21:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| -8.24% | O: -1.1% H: 3.89% C: 1.11%
year financial

Seer to Participate in the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-21 (Crawled : 21:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| 6.37% | O: 0.64% H: 0.63% C: -0.63%
conference health care

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
Published: 2024-02-06 (Crawled : 13:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| 0.0% | O: -0.6% H: 7.23% C: 6.63%
drug genetic biomarker

Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
Published: 2024-02-01 (Crawled : 21:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| -2.91% | O: -1.16% H: 1.76% C: 0.59%
report year financial results

Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
Published: 2023-12-21 (Crawled : 21:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| -4.57% | O: 0.57% H: 6.82% C: 3.41%
conference health care

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
Published: 2023-11-10 (Crawled : 14:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| 3.41% | O: -0.93% H: 0.0% C: -2.5%
services health diagnostics

Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
Published: 2023-11-08 (Crawled : 14:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| -2.91% | O: -4.07% H: 4.93% C: -1.21%
biotech solution year technology 500

Seer Reports Third Quarter 2023 Financial Results
Published: 2023-11-07 (Crawled : 21:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| -2.91% | O: -4.07% H: 4.93% C: -1.21%
financial results

Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
Published: 2023-11-01 (Crawled : 13:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| 1.83% | O: 0.0% H: 0.61% C: -0.61%
program

Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
Published: 2023-10-19 (Crawled : 20:00) - globenewswire.com
SEER | $1.67 0.6% 0.6% 730K

Professional, Scientific, and T...

| -9.73% | O: 0.0% H: 1.62% C: -1.62%
report financial results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001415889-24-007704	4	2024-03-12	2024-03-07	Sell	S	52857	1436285
0001415889-24-005087	4	2024-02-23	2024-02-06	Buy	A	1032901	1032901
0001415889-24-005087	4	2024-02-23	2024-02-06	Buy	A	529634	1489142
0001209191-24-002977	4	2024-02-08	2024-02-05	Sell	S	3608	328157